Uroalerts Men's Health Weekly

March 31, 2026

Videos

Peer-to-Peer Clinical Conversations

Cluster-Randomized Trial Targets Barriers to Mainstream Germline Testing for Veterans - Daniel Kwon

Daniel Kwon

Daniel Kwon reports on a VA-based trial designed to improve germline testing rates in prostate cancer patients.

Criteria for Selecting Sling vs Artificial Sphincter in Incontinence Treatment - Craig Comiter

Craig Comiter

In part four, Alan Wein concludes his discussion with Craig Comiter about male incontinence treatment preferences.

Beyond the Abstracts

One-Night Catheter Stay after Holmium Laser Enucleation of the Prostate: A Single-Center Comparative Study - Beyond the Abstract

MicroRNA-371-373 Cluster Extracellular Vesicle-Based Communication in Testicular Germ Cell Tumors - Beyond the Abstract

Articles

Editor Selected Abstracts and Commentaries

Androgen Deficiency

A Single Centre Study to Describe the Changes in Serum Testosterone Concentration Following Application of Testosterone Gel in Post-Menopausal Women With Hypoactive Sexual Desire Disorder (HSSD) Already Receiving This as Part of Usual Care in Conjunction

Male Infertility

Global Warming, Fertility, and Spermatogenesis Decline: Global and Regional Evidence from 195 Countries and Implications for Climate Adaptation Policy.

Oxidative Stress, Sperm DNA Fragmentation, or Both? Optimizing Test Selection in Male Infertility Evaluation.

The role of sperm DNA fragmentation testing in predicting IVF and PGT-A outcomes.

In Vitro Fertilization Utilization Rates and Outcomes in States with and without Insurance Coverage Mandates for Male Infertility Care - Beyond the Abstract

Peyronie's Disease

Contemporary Management Strategies for Peyronie's Disease: A Comprehensive Review.

Erectile Dysfunction

Low-intensity shockwave therapy for erectile dysfunction: An abridged Cochrane review.

A close look at the evidence on low-intensity shockwave therapy in erectile dysfunction-a systematic review and meta-analysis of randomized controlled trials.

Effectiveness of monthly maintenance low-intensity shockwave therapy added to a weekly protocol for erectile dysfunction: multicenter open-label randomized study.

BPH - Benign Prostatic Enlargement

Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS).

Long-term effects of testosterone therapy on prostate volume and LUTS in hypogonadal men: a retrospective study.

Pharmacotherapy of benign prostatic syndrome : Medications, innovations and future prospects.

Voiding symptoms aggravate with decreasing stromal/epithelial ratio and increasing glandular-epithelial content in patients undergoing laser enucleation for benign prostatic hyperplasia, independently from prostate size.

Image-Guided Robotic-Assisted Waterjet Ablation of Prostate (Aquablation) Versus Convective Water Vapor Thermal Therapy (Rezūm) in Patients with Prostate Volume Less than 80 Grams.

Penile & Urethral Cancers

Prognostic Factors of Survival in Patients with Surgically Treated Penile Squamous Cell Carcinoma: A Retrospective Cohort Analysis.

The identification of clinicopathological features predictive of recurrence following lymphadenectomy in penile cancer: A systematic review.

Radiotherapy combined with immunotherapy achieves clinical complete response in elderly metastatic penile cancer: a case report.

The Role of the Tumor Microenvironment in Penile Carcinoma and Emerging Therapeutic Concepts: A Review - Beyond the Abstract

Testicular Cancer

Inflammatory and Nested Testicular Sex Cord Tumors: Clinical and Molecular Characterization.

Review of the effect of atrazine on the HPG axes and steroidogenic pathways in males: relevance for testicular and prostate cancer.

Post-prostatectomy incontinence

Regenerative strategies for post-prostatectomy incontinence: stem cells, exosomes, and the path to clinical resolution.

Prostate Cancer

Conventional vs. Hypofractionated radiotherapy for high-risk prostate cancer (PCS5), randomized, non-inferiority, phase III trial: Post hoc analysis of radiation therapy toxicities and efficacy of IMRT compared to 3D-CRT.

From complexity to clarity: GPT-4 for patient-centered prostate cancer pathology reports.

Same-day fluorescence confocal microscopy of MRI-targeted prostate biopsies: A feasibility study.

Integrating Multiparametric MRI and PSMA PET Imaging in Prostate Cancer: Toward a Unified Diagnostic and Risk-Stratification Paradigm.

Integrated Urinary and Tissue Proteomic Signatures Reveal Core and Progression Biomarkers in MRI-Visible and MRI-Non-Visible Prostate Cancer.

Predicting 1-Year Trifecta Outcomes After High-Intensity Focused Ultrasound and Cryoablation for Low- and Intermediate-Risk Prostate Cancer.

Secondary primary tumors following iodine-125 low-dose-rate brachytherapy for localized prostate cancer.

Prospective Comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium[68Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial).

Disparities in Outcomes in Latino Subpopulations with Localized Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Analysis.

Differential Cytokine Profiles in Prostate Cancer Under Treatment: Implications for Prognosis and Synergistic Therapy Design.

Nerve-Sparing in High-Risk Prostate Cancer: Advantages and Pitfalls of Current Strategies and Technologies.

Quality and Usability of Prostate Cancer Information Generated by Artificial Intelligence Chatbots: A Comparative Analysis.

Hypoxia-Driven Mechanisms of Drug Resistance in Prostate Cancer.

Prognostic Value of Cycle 1 SPECT SUVmean in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA-617.

Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy.

Timing and Resolution of Bothersome Hot Flashes Following Short Course Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix, and Stereotactic Body Radiotherapy for Localized Prostate Cancer.

Antibody-drug conjugates in prostate cancer: current landscape and future directions.

Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer.

Aryl hydrocarbon receptor is critical for both AR-dependent and AR-indifferent enzalutamide resistance in castration-resistant prostate cancer.

Impact of PSMA PET on the management and clinical outcomes of patients with biochemical failure of prostate cancer after definitive treatment: a systematic review and meta-analysis.

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer.

Real-world precision medicine data in metastatic prostate cancer - a retrospective cohort study.

Early Detection of Prostate Cancer: Current Real-World Data from the VERSUS Study by d-uo.

A Culturally Tailored Mobile Health Intervention to Improve Quality of Life in Black Survivors With Prostate Cancer: Protocol for a Stratified Randomized Controlled Trial.

A Chemical Probe for Prostate-Specific Membrane Antigen for Real-Time Raman Imaging of Prostate Cancer Cells.

Association between short-term radiation-induced toxicity and oncological outcomes in high-risk prostate cancer: a retrospective single-centre cohort study.

Self-help cognitive behavioural therapy for hot flushes and night sweats during androgen deprivation therapy for prostate cancer: the MANCAN2 randomized controlled trial.

Risk factors for incidental prostate cancer following surgery for benign prostatic enlargement: A systematic review and meta-analysis.

Homologous Recombination Deficiency and Genomic Alterations in Advanced Prostate Cancer: Insights for Precision Therapy.

Cost-Effectiveness Analysis of 177Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer from a U.S. Health Care Perspective.

Clinical and Reader Associated Correlates of Clinically Significant MRI-Invisible Prostate Cancer based on Negative MRI.

Diagnostic Performance of Biparametric versus Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis: An Updated Systematic Review and Meta-analysis - Beyond the Abstract

Molecular Pathology of Rare Histologic Variants and Treatment-Resistant Lineages of Prostate Cancer - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC